HMGB1 promotes the synthesis of pro-il-1β and pro-il-18 by activation of p38 MAPK and NF-kB through receptors for advanced glycation end-products in macrophages

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1365-1370

  He, Qiang ^a   You, Hong ^a   Li, Xin Min ^a   Liu, Tian Hui ^a   Wang, Ping ^a   Wang, Bao En ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cancer.; High mobility group box1; Inflammation; NALP3 inflammasome

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CARRIER PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; NLRP3 PROTEIN, HUMAN;

ACUTE MONOCYTIC LEUKEMIA; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; MACROPHAGE; METABOLISM; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; CARRIER PROTEINS; CELL LINE, TUMOR; ENZYME ACTIVATION; HMGB1 PROTEIN; HUMANS; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; LEUKEMIA, MONOCYTIC, ACUTE; MACROPHAGES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, IMMUNOLOGIC;

EID: 84871514528     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1365     Document Type: Article

References (22)

1. Andersson U, Wang H, Palmblad K, et al (2000). High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, 565-70.
2. Bauernfeind FG, Horvath G, Stutz A, et al (2009). Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol, 183, 787-91.
3. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancer-related inflammation. Nature, 454, 436-44.
4. Carrascal MT, Mendoza L, Valcarcel M, et al (2003). Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res, 63, 491-7.
5. Eissa SA, Zaki SA, El-Maghraby et al (2005). Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst, 17, 51-5.
6. Klune JR, Dhupar R, Cardinal J, et al (2008). HMGB1: endogenous danger signaling. Mol Med, 14, 476-84.
7. Lewis AM, Varghese S, Xu H, et al (2006). Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med, 4, 48.
8. Lotze MT, Tracey KJ (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 5, 331-42.
9. Luan ZG, Zhang H, Yang PT, et al (2010). HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology, 215, 956-62.
10. Martinon F (2010). Signaling by ROS drives inflammasome activation. Eur J Immunol, 40, 616-9.
11. Merendino RA, Gangemi S, Ruello A, et al (2001). Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int J Biol Markers, 16, 126-9.
12. Okamoto M, Liu W, Luo Y, et al (2010). Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem, 285, 6477-88.
13. Park JS, Gamboni-Robertson F, He Q, et al (2006). High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol, 290, C917-24.
14. Schroder K, Tschopp J (2010). The inflammasomes. Cell, 140, 821-32.
15. Sha Y, Zmijewski J, Xu Z, et al (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol, 180, 2531-7.
16. Sims GP, Rowe DC, Rietdijk ST, et al (2010). HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol, 28, 367-88.
17. Tang D, Kang R, 3rd ZHJ, et al (2010). High-mobility group box 1 and cancer. Biochim Biophys Acta, 1799, 131-40.
18. Tschopp J, Schroder K (2010). NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production. Nat Rev Immunol, 10, 210-5.
19. Wang P, Cong M, Liu TH, et al (2010). Primary isolated hepatic oval cells maintain progenitor cell phenotypes aftertwo-year prolonged cultivation. J Hepatol, 53, 863-71.
20. Yang D, Chen Q, Yang H, et al (2007). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol, 81, 59-66.
21. Yang J, Chen L, Yang J, et al (2011). High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep, 39, 3361-7.
22. Ye ZB, Ma T, Li H, et al (2007). Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol, 13, 1747-51.